Patents by Inventor John Y. J. Wu

John Y. J. Wu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Toluene sulfonamide-containing anti-tumor composition and method of use thereof
    Patent number: 6727287
    Abstract: The invention relates to compositions which exhibit anti-tumor activity and which comprise a toluene sulfonamide at a concentration not previously recognized as being efficacious for this purpose. The compositions exhibit the ability to inhibit tumor growth, shrink (i.e., necrotize) tumors, and prevent tumor formation in humans. The invention also includes methods of making and using the compositions.
    Type: Grant
    Filed: April 16, 2001
    Date of Patent: April 27, 2004
    Assignee: PTS International, Inc.
    Inventors: John Y. J. Wu, Rocky C. S. Shih, Lester J. Wu
  • Toluene sulfonamide - containing anti- tumor composition and method of use thereof
    Publication number: 20030022843
    Abstract: The invention relates to compositions which exhibit anti-tumor activity and which comprise a toluene sulfonamide at a concentration not previously recognized as being efficacious for this purpose. The compositions exhibit the ability to inhibit tumor growth, shrink (i.e., necrotize) tumors, and prevent tumor formation in humans. The invention also includes methods of making and using the compositions.
    Type: Application
    Filed: April 16, 2001
    Publication date: January 30, 2003
    Inventors: John Y.J. Wu, Rocky C.S. Shih, Lester J. Wu
  • Anti-cancer drug and special tumor necrotizing agent
    Patent number: 5891454
    Abstract: This invention provides a novel pharmaceutical composition exhibiting remarkable anti-cancer, and cancer necrotizing properties as well as other desirable pharmacological properties. The composition is a mixture of toluene sulfonamide (e.g. para toluene sulfonamide) with a specifically designed solution which consists of polyethylene glycol, 2-ethyl-1,3-hexanediol, propanediol, decanedioic acid, dimethyl, sulfoxide and ethanol. The composition demonstrates promising therapeutical activity in preliminary human clinical tests and exhibits very little undesirable side effects.
    Type: Grant
    Filed: March 28, 1997
    Date of Patent: April 6, 1999
    Assignees: Alexander Wu, John Wu, Jenny Gwo Wu, Lester Wu
    Inventor: John Y. J. Wu